Patents by Inventor Kristen Tomita

Kristen Tomita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELISA for VEGF
    Patent number: 7541160
    Abstract: The vascular endothelial growth factor (VEGF) activity in a patient's bloodstream or other biological sample can serve as a diagnostic and prognostic index for cancer, diabetes, heart conditions, and other pathologies. Antibody-sandwich ELISA method and kits for VEGF as an antigen were developed to detect VEGF levels in biological samples from animal models and human patients and are used as a diagnostic/prognostic index.
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: June 2, 2009
    Inventors: David Tai Wai Fei, Kristen Tomita
  • ELISA for VEGF
    Publication number: 20070202558
    Abstract: The vascular endothelial growth factor (VEGF) activity in a patient's bloodstream or other biological sample can serve as a diagnostic and prognostic index for cancer, diabetes, heart conditions, and other pathologies. Antibody-sandwich ELISA method and kits for VEGF as an antigen were developed to detect VEGF levels in biological samples from animal models and human patients and are used as a diagnostic/prognostic index.
    Type: Application
    Filed: November 1, 2004
    Publication date: August 30, 2007
    Applicant: GENENTECH, INC.
    Inventors: David Fei, Kristen Tomita
  • ELISA for VEGF
    Patent number: 6855508
    Abstract: The vascular endothelial growth factor (VEGF) activity in a patient's bloodstream or other biological sample can serve as a diagnostic and prognostic index for cancer, diabetes, heart conditions, and other pathologies. Antibody-sandwich ELISA method and kits for VEGF as an antigen were developed to detect VEGF levels in biological samples from animal models and human patients and are used as a diagnostic/prognostic index.
    Type: Grant
    Filed: August 5, 2002
    Date of Patent: February 15, 2005
    Assignee: Genentech, Inc.
    Inventors: David Tai Wai Fei, Kristen Tomita
  • ELISA for VEGF
    Publication number: 20030044865
    Abstract: The vascular endothelial growth factor (VEGF) activity in a patient's bloodstream or other biological sample can serve as a diagnostic and prognostic index for cancer, diabetes, heart conditions, and other pathologies. Antibody-sandwich ELISA method and kits for VEGF as an antigen were developed to detect VEGF levels in biological samples from animal models and human patients and are used as a diagnostic/prognostic index.
    Type: Application
    Filed: August 5, 2002
    Publication date: March 6, 2003
    Applicant: Genentech, Inc.
    Inventors: David Tai Wai Fei, Kristen Tomita